🇯🇵 Direct Acting Antivirals in Japan

Direct Acting Antivirals (Direct Acting Antivirals) regulatory status in Japan.

Marketing authorisations

PMDA

  • Application: Sovaldi Initial Approval
  • Local brand name: Sovaldi Initial Approval
  • Status: approved

Read official source →

PMDA

  • Application: Sovaldi Partial Change Approval
  • Local brand name: Sovaldi Partial Change Approval
  • Status: approved

Read official source →

Direct Acting Antivirals in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Direct Acting Antivirals approved in Japan?

Yes. PMDA has authorised it; PMDA has authorised it.

Who is the marketing authorisation holder for Direct Acting Antivirals in Japan?

Medical University of Warsaw is the originator. The local marketing authorisation holder may differ — check the official source linked above.